CRNX
Price
$45.56
Change
-$0.47 (-1.02%)
Updated
Nov 28, 02:00 PM (EDT)
Capitalization
4.32B
96 days until earnings call
Intraday BUY SELL Signals
TVTX
Price
$35.44
Change
-$0.82 (-2.26%)
Updated
Nov 28, 02:00 PM (EDT)
Capitalization
3.25B
83 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRNX vs TVTX

Header iconCRNX vs TVTX Comparison
Open Charts CRNX vs TVTXBanner chart's image
Crinetics Pharmaceuticals
Price$45.56
Change-$0.47 (-1.02%)
Volume$349.17K
Capitalization4.32B
Travere Therapeutics
Price$35.44
Change-$0.82 (-2.26%)
Volume$82.97K
Capitalization3.25B
CRNX vs TVTX Comparison Chart in %
CRNX
Daily Signal:
Gain/Loss:
TVTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRNX vs. TVTX commentary
Nov 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a StrongBuy and TVTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 29, 2025
Stock price -- (CRNX: $46.03 vs. TVTX: $36.26)
Brand notoriety: CRNX and TVTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 57% vs. TVTX: 59%
Market capitalization -- CRNX: $4.32B vs. TVTX: $3.25B
CRNX [@Biotechnology] is valued at $4.32B. TVTX’s [@Biotechnology] market capitalization is $3.25B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileTVTX’s FA Score has 1 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • TVTX’s FA Score: 1 green, 4 red.
According to our system of comparison, TVTX is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 3 TA indicator(s) are bullish while TVTX’s TA Score has 2 bullish TA indicator(s).

  • CRNX’s TA Score: 3 bullish, 4 bearish.
  • TVTX’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, CRNX is a better buy in the short-term than TVTX.

Price Growth

CRNX (@Biotechnology) experienced а +7.30% price change this week, while TVTX (@Biotechnology) price change was +2.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.81%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +75.56%.

Reported Earning Dates

CRNX is expected to report earnings on Mar 04, 2026.

TVTX is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (+8.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($4.32B) has a higher market cap than TVTX($3.25B). TVTX YTD gains are higher at: 108.152 vs. CRNX (-9.975). TVTX has higher annual earnings (EBITDA): -22.58M vs. CRNX (-419.62M). CRNX has more cash in the bank: 1.2B vs. TVTX (255M). CRNX has less debt than TVTX: CRNX (49.9M) vs TVTX (330M). TVTX has higher revenues than CRNX: TVTX (436M) vs CRNX (1.39M).
CRNXTVTXCRNX / TVTX
Capitalization4.32B3.25B133%
EBITDA-419.62M-22.58M1,858%
Gain YTD-9.975108.152-9%
P/E RatioN/AN/A-
Revenue1.39M436M0%
Total Cash1.2B255M469%
Total Debt49.9M330M15%
FUNDAMENTALS RATINGS
CRNX vs TVTX: Fundamental Ratings
CRNX
TVTX
OUTLOOK RATING
1..100
2127
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
4761
SMR RATING
1..100
94100
PRICE GROWTH RATING
1..100
4135
P/E GROWTH RATING
1..100
10032
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TVTX's Valuation (85) in the Biotechnology industry is in the same range as CRNX (86) in the Pharmaceuticals Major industry. This means that TVTX’s stock grew similarly to CRNX’s over the last 12 months.

CRNX's Profit vs Risk Rating (47) in the Pharmaceuticals Major industry is in the same range as TVTX (61) in the Biotechnology industry. This means that CRNX’s stock grew similarly to TVTX’s over the last 12 months.

CRNX's SMR Rating (94) in the Pharmaceuticals Major industry is in the same range as TVTX (100) in the Biotechnology industry. This means that CRNX’s stock grew similarly to TVTX’s over the last 12 months.

TVTX's Price Growth Rating (35) in the Biotechnology industry is in the same range as CRNX (41) in the Pharmaceuticals Major industry. This means that TVTX’s stock grew similarly to CRNX’s over the last 12 months.

TVTX's P/E Growth Rating (32) in the Biotechnology industry is significantly better than the same rating for CRNX (100) in the Pharmaceuticals Major industry. This means that TVTX’s stock grew significantly faster than CRNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRNXTVTX
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
71%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 9 days ago
76%
Bearish Trend 8 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
85%
Aroon
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signal:
Gain/Loss:
TVTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PBQQX27.220.21
+0.78%
PGIM Jennison Blend R6
VWUAX215.581.53
+0.71%
Vanguard US Growth Admiral™
ESGEX22.260.14
+0.63%
Reynders McVeigh Core Equity Instl
MMNGX19.510.08
+0.41%
MassMutual Mid Cap Growth Y
JMNSX16.080.03
+0.19%
JPMorgan Research Market Neutral I

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
+2.95%
XNCR - CRNX
60%
Loosely correlated
+0.70%
NUVL - CRNX
53%
Loosely correlated
-0.73%
CLDX - CRNX
52%
Loosely correlated
+1.32%
IDYA - CRNX
52%
Loosely correlated
+1.10%
DYN - CRNX
52%
Loosely correlated
+1.78%
More

TVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TVTX has been loosely correlated with ROIV. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TVTX jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TVTX
1D Price
Change %
TVTX100%
+0.69%
ROIV - TVTX
40%
Loosely correlated
+0.05%
ARWR - TVTX
39%
Loosely correlated
+23.34%
XNCR - TVTX
38%
Loosely correlated
+0.70%
CRNX - TVTX
38%
Loosely correlated
+2.95%
RCUS - TVTX
37%
Loosely correlated
+5.27%
More